EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 23-Jun-2026 02:15 ET (23-Jun-2026 06:15 GMT/UTC)

16-Mar-2026

Impact Journals to participate at AACR Annual Meeting 2026 in San Diego

Impact Journals LLC
Meeting Announcement

BUFFALO, NY – March 16, 2025 – Impact Journals (publisher of Aging-US, Oncotarget, Oncoscience, and Genes & Cancer), is pleased to announce its participation as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2026. The meeting will take place April 17–22, 2026, at the San Diego Convention Center in San Diego, CA.

16-Mar-2026

Rewiring tumor immunity: A hidden protein halts colorectal cancer spread

China Anti-Cancer Association
Peer-Reviewed Publication

Cancer progression is not driven solely by tumor cells but also by their surrounding immune environment.

Journal: Cancer Biology & Medicine

16-Mar-2026

New alliance clinical trial aims to improve outcomes in brain tumors

Alliance for Clinical Trials in Oncology
Business Announcement

A new clinical trial led by the Alliance for Clinical Trials in Oncology will investigate if a combination of drug therapies after radiation therapy improves outcomes for people with newly-diagnosed, grade 3 IDH-mutant astrocytoma, a type of brain cancer. Supported in part by a grant from the National Cancer Institute, the study (Alliance A072301) will look at whether adding the oral medication vorasidenib to the standard oral chemotherapy can help keep the cancer from coming back after radiation.

Funder: Alliance for Clinical Trials in Oncology Foundation

16-Mar-2026

Uncovering a key signaling pathway linking liver cancer and fibrosis

Institute of Science Tokyo
Peer-Reviewed Publication

New molecular insights into the link between hepatocellular carcinoma and intratumoral fibrosis could lead to better treatment strategies, report researchers from Institute of Science Tokyo. Through a comprehensive analysis involving clinical data and in vitro and in vivo experiments, they revealed that the SPP1–CD44–Hedgehog signaling pathway is a key driver of fibrosis in liver tumors, hinting at its potential as a therapeutic target.

Journal: Cancer Science
Funder: Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), Japan Agency for Medical Research and Development, Princess Takamatsu Cancer Research Fund

16-Mar-2026

Novel cancer drug delivery system improves Paclitaxel absorption

Osaka Metropolitan University
Peer-Reviewed Publication

Osaka Metropolitan University researchers developed a DDS that specifically transports Paclitaxel (PTX), a relatively large and poorly water-soluble anticancer drug, to cancerous tissue. They utilized the L-PGDS enzyme as a novel DDS carrier to efficiently transport PTX.

Journal: ACS Omega
Funder: Japan Society for the Promotion of Science

15-Mar-2026

The cost of survival: Women more likely to survive cancer but suffer more severe side effects

Adelaide University
Peer-Reviewed Publication

Women are more likely to survive cancer than men but face a higher risk of serious and adverse side effects from treatment, according to a landmark international study from Adelaide University.

Published in the Journal of the National Cancer Institute (JNCI) and conducted in partnership with a international collaborators, the research identified consistent differences between male and female cancer patients in both survival and treatment toxicity.

Female patients had a 21% lower risk of death compared with male patients, yet a 12% higher risk of severe toxicities.

Journal: JNCI Journal of the National Cancer Institute
Funder: Emerging Leader Investigator Fellowship from the National Health and Medical Research Council, Australia, The Hospital Research Foundation, Tour de Cure

15-Mar-2026

Timely scan could save lives of A&E patients with blood in urine

European Association of Urology
Reports and Proceedings

One in ten emergency patients with visible blood in their urine die within three months of presenting at A&E, new research has found. The WASHOUT study, presented at the European Association of Urology Congress (EAU26) in London, found that a scan within 48 hours could reduce this risk.

Meeting: EAU26 European Association of Urology Congress

14-Mar-2026

Prostate cancer screening as good as breast cancer screening, say researchers

European Association of Urology
Reports and Proceedings

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.

Meeting: EAU26 European Association of Urology Congress

13-Mar-2026

The power of photonics

University of Illinois Grainger College of Engineering
Peer-Reviewed Publication

Timing is critical in diagnosing diseases such as cancer. Researchers within The Grainger College of Engineering at the University of Illinois Urbana-Champaign used a historically underappreciated tiny powerhouse to detect diseases sooner.

Journal: Chemical Reviews

13-Mar-2026

Bursting cancer-seeking microbubbles to deliver deadly drugs

Duke University
Peer-Reviewed Publication

Engineers at Duke University have demonstrated a technique that uses microbubbles and ultrasound to help relatively large cancer drugs enter tumor cells and cause them to self-destruct.

Journal: Proceedings of the National Academy of Sciences